Please login to the form below

Not currently logged in
Email:
Password:

PPRS

This page shows the latest PPRS news and features for those working in and with pharma, biotech and healthcare.

UK appoints pharma veteran to 'streamline' NHS costs

UK appoints pharma veteran to 'streamline' NHS costs

These will include the Pharmaceutical Price Regulation Scheme (PPRS). The current version of the five-year scheme began in 2014 and negotiations on its successor are due to begin this Autumn. ... limit generic prices for medicines that are not covered by

Latest news

  • Norgine UK re-joins ABPI Norgine UK re-joins ABPI

    The Netherlands-based firm resigned its ABPI membership in 2008 in protest over a perceived lack of representation for smaller, specialised pharmaceutical developers, taking particular issue with talks on the PPRS.

  • UK government tables bill on medicine pricing reforms UK government tables bill on medicine pricing reforms

    A central objective in the shake-up is to remove disparities between the voluntary Pharmaceutical Price Regulation Scheme (PPRS) and the statutory price control system for branded drugs sold by companies ... who do not sign up to the PPRS, says the

  • UK pharma's contribution to NHS hits £1bn mark UK pharma's contribution to NHS hits £1bn mark

    New figures from the UK pharma industry claim the sector has contributed more than £1bn to the NHS as part of the Pharmaceutical Payment Regulation Scheme (PPRS). ... The PPRS controls the price of branded medicines in the NHS and results from a

  • Roche faces Kadcyla pricing pressure in the UK Roche faces Kadcyla pricing pressure in the UK

    Set up in 2010, the CDF was originally intended as a stop-gap measure until the government could replace the existing Pharmaceutical Price Regulation Scheme (PPRS) with a new value-based

  • National Audit Office agrees CDF is 'unsustainable' National Audit Office agrees CDF is 'unsustainable'

    Pharmaceutical Price Regulation Scheme (PPRS) with a new value-based pricing model stalled.

More from news
Approximately 9 fully matching, plus 114 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest appointments

  • EFPIA's Richard Torbett to move to the ABPI EFPIA's Richard Torbett to move to the ABPI

    with the Department of Health around the PPRS.”. ... At the ABPI Torbett will focus on pricing, the Pharmaceutical Price Regulation Scheme (PPRS), health technology assessments (HTA) and value assessment, as well as market access in the UK.

  • ABPI names Amgen’s UK head as president ABPI names Amgen’s UK head as president

    of Health to secure the 2014 PPRS.

  • ABPI appoints value and access manager ABPI appoints value and access manager

    initiatives. “ These include the implementation of the new PPRS scheme, working with NICE on value based assessment and helping our members with the changing NHS landscape whilst continuing to push for

  • Pfizer's Jonathan Emms to be ABPI president Pfizer's Jonathan Emms to be ABPI president

    The UK industry is in the midst of preparing for the introduction of the new version of the Pharmaceutical Pricing Regulatory Scheme ( PPRS) in January, final details of which were published ... Emms' appointment comes after he and his company expressed

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Unique forum will unite NHS and industry to drive innovation

    will be a panellist on a session about‘ Negotiating the PPRS – Assessing what comes next’. ... An overview of the agenda ·. Candid and open discussion about access and pricing as the deadline for completing PPRS negotiations rapidly approaches ·

  • Michael Sobanja talks market access video 2

    Michael Sobanja talks market access video 2. Mike Sobanja explores and discusses what the Pharmaceutical Price Regulation Scheme (PPRS) means for the industry moving forward.

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Adelphi Research UK

Adelphi Research UK is a healthcare insight partner. We uniquely blend robust market research with a consultancy approach, to guide...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics